obama care health

(Bloomberg) — Billionaire Mukesh Ambani’s group is getting into genetic mapping, looking to make a health care trend led by disruptive US startups like 23andMe more affordable and widespread in India’s growing consumer market. Most Read from Bloomberg The energy-to-ecommerce conglomerate will roll out within weeks a comprehensive 12,000-rupee ($145) genome sequencing test, according to …

Asia’s Richest Man Mukesh Ambani to Foray Into Genome Testing with $145 Kit Read More »